Stock Groups

Pfizer COVID-19 vaccine partially protective against Omicron

by Mike Robinson

[ad_1]

© Reuters. FILE PHOTO – Vials of Pfizer BioNTech are shown in Geneva, Switzerland at the vaccination centre on February 3, 2021. REUTERS/Denis Balibouse

(Reuters) – Omicron, a coronavirus variant that can partly evade protection Pfizer Bloomberg News reported that Inc (NYSE 🙂 and BioNTech, its partner, have released the COVID-19 vaccination vaccine.

According to Alex Sigal (head of the laboratory), the evasion may not be complete. A booster shot might provide extra protection.

Omicron, a variant first discovered in Southern Africa last month has raised alarms worldwide about a new surge in infection. More than two dozen countries, from Japan to America, have reported cases.

It was classified by the World Health Organization as a “variant concern” on November 26th, but there were no supporting evidence for the development of new vaccines that specifically target the Omicron mutation.

Sigal has not yet responded to Reuters’s request for comment.

Disclaimer: Fusion MediaThis website does not provide accurate and current data. CFDs are stocks, indexes or futures. The prices of Forex and CFDs are not supplied by exchanges. They are instead provided by market makers. As such, the prices might not reflect market values and could be incorrect. Fusion Media does not accept any liability for trade losses caused by the data.

Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this information. This includes data including charts and buy/sell signal signals. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.

[ad_2]